John McLaughlin
Director · Sonoma Pharmaceuticals, Inc.
Individual
- 2026
- Jul 10, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at John McLaughlin's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Catalyst4, Inc. - $98.71M in MPLT purchases and sales in the last 12 months
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
- Paul A. Mahon - $93.78M in UTHR purchases and sales in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- Steven Leonard Chapman - $90.79M in NTRA purchases and sales in the last 12 months
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John McLaughlin?
John McLaughlin is a corporate insider, tracked as Director of Sonoma Pharmaceuticals, Inc. (SNOA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did John McLaughlin last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 2 filings going back to 2026.